drugset / Trial / NCT04721457

The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load

NCT04721457

Phase 4 Completed 90 enrolled King Abdulaziz University
RandomizedParallel-groupDouble-blindPrevention

Summary

Preoperative antiseptic mouth rinses have been widely used as a standard protocol before routine dental treatment reduces oral microorganism counts. During dental procedures, aerosolized microorganisms contaminate the dental environment and nearby surfaces and remain suspended for 4 hours. Thus, the reduction in the number of aerosolized microorganisms by pre-procedural rinsing may reduce cross-contamination between dentists, office personnel, and patients. Recent reviews have advocated the use of preoperative rinsing to control and reduce the risk of SARS-CoV-2 transmission. However, no clinical studies have been done yet to support the effectiveness of any pre-procedural oral rinses against SARS-CoV-2. The proposed study will mitigate the spread of COVID-19 disease in dental healthcare facilities and ensure the patients' good health and healthcare workers. The purpose of this clinical trial is to compare the efficacy of four commercially available mouth rinses povidone-iodine (PVP-I), hydrogen peroxide (H2O2), cetylpyridinium chloride (CPC), sodium hypochlorite (NaOCl) on the salivary SARS-CoV-2 viral load at four-time points (baseline and 5-, 30-, and 60-min post rinsing) relative to two control groups (distilled water and no-rinse) in a cohort of positive COVID-19 patients.

Timeline

Start
2021-01-03
Primary completion
2021-03-28
Completion
2021-12-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetylpyridinium Small molecule 0.075 % Oral
Comparator Hydrogen Peroxide Small molecule 1.5 % Oral
Comparator Povidone-Iodine Other / unclassified 1 % Oral
Comparator Sodium Hypochlorite Unknown 0.1 % Oral

Indications